Cornerstone Planning Group LLC Exelixis, Inc. Transaction History
Cornerstone Planning Group LLC
- $624 Billion
- Q3 2025
A detailed history of Cornerstone Planning Group LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Cornerstone Planning Group LLC holds 12 shares of EXEL stock, worth $499. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12
Previous 17
29.41%
Holding current value
$499
Previous $637,000
26.69%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding EXEL
# of Institutions
697Shares Held
259MCall Options Held
1.52MPut Options Held
1.61M-
Black Rock Inc. New York, NY33.5MShares$1.4 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA26.1MShares$1.09 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA19.5MShares$812 Million3.48% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.5MShares$644 Million0.9% of portfolio
-
State Street Corp Boston, MA11.1MShares$463 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $13.4B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...